Toshiki Oka Selected Research

Toshiki Oka Research Topics

6	Neoplasms (Cancer) 12/2022 - 02/2018
4	Renal Cell Carcinoma (Grawitz Tumor) 09/2023 - 07/2020
2	Neoplasm Metastasis (Metastasis) 11/2020 - 07/2020
1	Lymphatic Metastasis 03/2023
1	Prostatic Neoplasms (Prostate Cancer) 03/2023
1	Headache (Headaches) 12/2022
1	Hypertension (High Blood Pressure) 12/2022
1	Residual Neoplasm 03/2022
1	Hematuria 03/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Cysts 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2021
1	Adrenocortical Carcinoma 11/2020
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 11/2020
1	Carcinoma (Carcinomatosis) 07/2019
1	Diverticulum 07/2019
1	Foreign Bodies (Foreign Body) 04/2018

2	NivolumabIBA 01/2021 - 07/2020
1	Bacterial DNAIBA 09/2023
1	Biomarkers (Surrogate Marker)IBA 09/2023
1	DNA (Deoxyribonucleic Acid)IBA 09/2023
1	Therapeutic UsesIBA 03/2023
1	enzalutamideIBA 03/2023
1	3-Iodobenzylguanidine (Iobenguane)IBA 12/2022
1	SteroidsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 11/2020
1	Mitotane (Lysodren)FDA Link 11/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	Gemcitabine FDA Link 11/2020
1	Rituximab (Mabthera)FDA Link 11/2020
1	Capecitabine (Xeloda)FDA Link 11/2020
1	pazopanib FDA Link 07/2020
1	Everolimus FDA Link 07/2020
1	Sunitinib (Sutent)FDA Link 07/2020
1	Axitinib (AG 013736)IBA 07/2020
1	PlasticsIBA 04/2018

3	Drug Therapy (Chemotherapy) 03/2022 - 11/2020
3	Nephrectomy 01/2021 - 07/2019
2	Radiotherapy 03/2022 - 07/2020
2	Therapeutics 01/2021 - 11/2020
1	Castration 03/2023
1	Transurethral Resection of Bladder 03/2022
1	Cystectomy 03/2022
1	Chemoradiotherapy 01/2021
1	Hysterectomy 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Operative Surgical Procedures 01/2021
1	Aftercare (After-Treatment) 11/2020
1	Cystostomy (Suprapubic Cystostomy) 04/2018
1	Pelvic Exenteration 02/2018
1	Urinary Diversion (Ileal Conduit) 02/2018